Shares of Moderna jumped 5.04% to $150.21 at 10:15 EST on Thursday, following yesterday’s downward trend. The Nasdaq Stock Market is sliding 0.05% to $12,349.40, following yesterday’s downward trend, on what so far seems, a somewhat negative trend exchanging session today.

Moderna’s last close was $141.01, 18.83% below its 52-week high of $178.50.

Moderna’s Sales

Moderna’s sales growth is 1425.2% for the present quarter and 12348.6% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 528.6% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Top and Bottom Yearly Value

Moderna’s stock is valued at $150.21 at 10:15 EST, way under its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s worth is way higher than its 50-day moving average of $84.72 and way higher than its 200-day moving average of $72.17.

Previous days news about Moderna

Moderna falls after merck sells stake in the vaccine maker. According to yesterday’s article on Bloomberg Quint, “Moderna Inc. fell in premarket trading in New York after Merck & Co. said it sold its stake in the biotechnology company that’s in the midst of developing a Covid-19 vaccine.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here